Tirzepatide vs Semaglutide vs Retatrutide — the Core Difference
The defining difference between these three peptides is receptor coverage: Semaglutide is a single GLP-1 agonist, Tirzepatide adds GIP to become a dual agonist, and Retatrutide adds glucagon to become a triple agonist. Each added receptor changes the experimental profile, which is why labs treat them as distinct compounds rather than interchangeable options.
All three are synthetic, fatty-acid-acylated peptides in the same incretin research family, and all three share identical sourcing expectations — ≥98% HPLC purity with mass-spectrometry confirmation and vacuum-sealed lyophilized storage.
Side-by-Side Comparison
| Property | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Receptor targets | GLP-1 only | GIP + GLP-1 | GIP + GLP-1 + glucagon |
| Molecular weight | ~4113 Da | ~4813 Da | ~4840 Da |
| Agonist class | Single | Dual | Triple |
| Storage | -20°C lyophilized | -20°C lyophilized | -20°C lyophilized |
| Purity standard | ≥98% HPLC + MS | ≥98% HPLC + MS | ≥98% HPLC + MS |
Which One Matches Your Protocol?
Choose Semaglutide for single-pathway GLP-1 studies, Tirzepatide when your protocol requires dual GIP/GLP-1 engagement, and Retatrutide when glucagon-receptor activity is part of your experimental design. If you are running a head-to-head comparison, source all compounds from the same supplier so purity and fill weight stay constant across the set.
- Semaglutide: the baseline GLP-1 agonist, most established in the literature
- Tirzepatide: dual agonism, the middle ground most labs standardize on
- Retatrutide: triple agonism, the newest and least-studied of the three
FAQ
What is the main difference between Semaglutide and Tirzepatide?
Tirzepatide engages both GIP and GLP-1 receptors, while Semaglutide acts only on GLP-1. This dual action is the core structural difference and the reason they are not interchangeable in research.
Is Retatrutide just a stronger Tirzepatide?
No — Retatrutide adds a third target, the glucagon receptor, which changes its profile rather than simply making it stronger. It is a distinct compound, not an upgraded version of Tirzepatide.
Do all three require the same storage conditions?
Yes — all three are lyophilized peptides that should be stored at -20°C in vacuum-sealed vials protected from light. The storage and purity requirements are identical across the three.
Important: All products are sold strictly for laboratory and research purposes only — not for human or veterinary use. No medical or dosing guidance is provided.